A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.

Saved in:
Bibliographic Details
Title: A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.
Authors: Diggin S; Cumulus Neuroscience Ltd., Belfast, United Kingdom., Rueda-Delgado L; Cumulus Neuroscience Ltd., Dublin, Ireland., Buick A; Cumulus Neuroscience Ltd., Belfast, United Kingdom., Dyer JF; Cumulus Neuroscience Ltd., Belfast, United Kingdom., Alexander-Sefre A; Cumulus Neuroscience Ltd., Belfast, United Kingdom., Barbey F; Cumulus Neuroscience Ltd., Dublin, Ireland., Rowe JB; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Muhammed K; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom., Harel BT; Neuroscience Translational Medicine, Takeda Pharmaceuticals, Cambridge, MA, United States., Hansen BJ; Janssen Research & Development, LLC, a Johnson & Johnson Company, Pennsylvania, PA, United States., Tunbridge E; CNS Diseases Research, Boehringer Ingelheim, Biberach, Germany., Lai R; GSK, Stevenage, United Kingdom., Hawellek DJ; Pharma Research and Early Development (pRED), Hoffmann-La Roche Ltd., Basel, Switzerland., Hake AM; Eli Lilly and Company, Indianapolis, IN, United States.; Department of Neurology, Indiana University School of Medicine, Indianapolis, IN, United States., Marston H; CNS Diseases Research, Boehringer Ingelheim, Biberach, Germany., Oswal A; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; MRC Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom., Coulthard E; Bristol Medical School, University of Bristol, Bristol, United Kingdom., Pattan V; NHS Forth Valley, Scotland, United Kingdom., Evans V; Re:Cognition Health, Plymouth, Devon, United Kingdom., Gibson S; NHS Forth Valley, Scotland, United Kingdom., Kipps C; Department of Neurology, Wessex Neurological Centre, Southampton, United Kingdom.; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom., Kozak R; Neuroscience Translational Medicine, Takeda Pharmaceuticals, Cambridge, MA, United States., Mannering N; Re:Cognition Health, Plymouth, Devon, United Kingdom.; Re:Cognition Health, Guildford, Surrey, United Kingdom., Moss M; Biogen Inc., Cambridge, MA, United States., Nguyen V; Department of Anatomy and Neurobiology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, United States., Ruddock K; NHS Forth Valley, Scotland, United Kingdom., Shinobu LA; Neuro TRC, Bristol Myers Squibb, Cambridge, MA, United States., Toniolo S; Nuffield Department of Clinical Neurosciences, University of Oxford, Oxford, United Kingdom.; MRC Brain Network Dynamics Unit, University of Oxford, Oxford, United Kingdom., Murphy B; Cumulus Neuroscience Ltd., Dublin, Ireland.
Source: Frontiers in digital health [Front Digit Health] 2026 Jun 26; Vol. 8, pp. 1840966. Date of Electronic Publication: 2026 Jun 26 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101771889 Publication Model: eCollection Cited Medium: Internet ISSN: 2673-253X (Electronic) Linking ISSN: 2673253X NLM ISO Abbreviation: Front Digit Health Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2673-253X
DOI:10.3389/fdgth.2026.1840966